Viatorr CX Case-control Study for Complications of Portal Hypertension
NCT ID: NCT03083925
Last Updated: 2019-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2016-05-23
2018-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Performance Study of Large Hole Vascular Closure Device FIV
NCT03423602
Safety and Performance Study of Large Hole Vascular Closure Device
NCT01943344
Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study
NCT04799769
Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device
NCT01478061
Evaluation of the GORE® C3 Delivery System Module
NCT01398332
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Of these patients, 20 patients will receive Viatorr CX and the assessement of the width of the stent as outlined in the JVIR-paper published this year.
The Viatorr and BMS controls with similar age, gender, Child, MELD and indication for TIPS.
A total of 125 patients with the primary composite-endpoint HE/readmission will be investigated Secondary endpoints are liver injury, cardiac function, response to TIPS and the passive expansion of the stents in real life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bare metal stent (BMS) TIPS
retrospective patients receiving BMS-TIPS for treatment of complications of portal hypertension.
TIPS
Transjugular Intrahepatic Portosystemic Shunt
Regular Viatorr (RV) TIPS
retrospective patients receiving RV-TIPS for treatment of complications of portal hypertension.
TIPS
Transjugular Intrahepatic Portosystemic Shunt
Viatorr Control Expansion (VCX)TIPS
prospective patients receiving VCX-TIPS for treatment of complications of portal hypertension.
TIPS
Transjugular Intrahepatic Portosystemic Shunt
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TIPS
Transjugular Intrahepatic Portosystemic Shunt
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bonn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonel Trebicka
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonel Trebicka, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Laboratory for Liver Fibrosis and Portal Hypertension
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratory for Liver Fibrosis and Portal Hypertension
Bonn, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TIPS-CX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.